Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Snapshots: potential new treatments for melanoma presented at ASCO

June 29, 2009

ASCO snapshots: data from phase II trials of potential treatments for lung cancer disclosed

June 29, 2009

Silence Therapeutics doses first patient in ATU-027 trial for solid tumors

June 26, 2009

Cytopia files IND with FDA for JAK2 inhibitor CYT-387

June 26, 2009

ActoGeniX receives FDA approval to initiate phase Ib clinical trials of AG-013 in cancer

June 26, 2009

Provectus initiates compassionate-use program in Australia for PV-10 in cancer

June 25, 2009

Enzon initiates phase II trial of cancer drug PEG-SN38 in metastatic colon cancer

June 25, 2009

Prospect Therapeutics to develop GCS-100 for blood-borne cancers

June 25, 2009

Takeda presents novel MEK/ERK inhibitors as oncolytics

June 25, 2009

Sarcoma treatment snapshots from ASCO

June 25, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...